Electroacupuncture alleviates obesity-associated inflammatory responses by inhibiting dendritic cell migration.

Researchers investigating how electroacupuncture might help with obesity-related inflammation have discovered a promising immune system mechanism. Scientists at a university laboratory studied obese mice fed a high-fat diet and treated some with electroacupuncture while observing changes in their body weight and tissue inflammation. The study, published in International Immunopharmacology, revealed that electroacupuncture significantly reduced body weight and decreased inflammation in visceral fat tissue surrounding the intestines. The researchers found that electroacupuncture works by preventing specialized immune cells called dendritic cells from migrating from the intestines into fat tissue, where they would normally trigger inflammatory responses. Using advanced tracking techniques, they observed that electroacupuncture reduced levels of inflammatory molecules like TNF-alpha and IL-1beta in both blood and fat tissue. The treatment also decreased the accumulation of other inflammatory immune cells, including macrophages and T-cells, in adipose tissue. The mechanism appears to involve a protein called CCR7, which normally guides dendritic cells to move between tissues. By reducing CCR7 expression, electroacupuncture may interrupt this inflammatory cell trafficking. While this animal study provides important mechanistic insights into how acupuncture might address obesity-related inflammation, human clinical trials are needed to confirm these effects in people struggling with weight management and metabolic health issues. These findings add to growing evidence that acupuncture has measurable effects on immune function beyond pain relief. Patients interested in electroacupuncture for weight management should consult with a licensed acupuncturist trained in this specialized technique.

This murine study investigated electroacupuncture's effects on obesity-associated inflammation, specifically examining dendritic cell (DC) migration mechanisms. C57BL/6 mice on high-fat diet received EA treatment; outcomes were assessed via H&E staining, Western blot, ELISA, immunofluorescence, and flow cytometry. Results demonstrated significant body weight reduction and decreased adipose tissue inflammation. EA treatment reduced pro-inflammatory cytokines (TNF-α, IL-1β) in serum and mesenteric adipose tissue (MAT), with decreased macrophage and T-cell infiltration confirmed by IF analysis. Flow cytometry revealed reduced DC accumulation in mesenteric lymph nodes and MAT. CM-DiI tracing demonstrated EA suppressed intestinal DC migration to MAT. Mechanistically, EA downregulated CCR7 expression in intestinal tissue, suggesting modulation of CCR7-associated DC trafficking pathways. Clinical relevance: EA may ameliorate obesity-induced inflammation through immunomodulatory mechanisms involving DC migration inhibition, offering potential therapeutic applications for metabolic inflammation management beyond traditional weight loss interventions.